TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 73 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $416,582 | +31.1% | 11,047 | +31.9% | 0.00% | – |
| Q2 2023 | $317,702 | +767.4% | 8,376 | +456.2% | 0.00% | – |
| Q1 2023 | $36,627 | +89.7% | 1,506 | +126.5% | 0.00% | – |
| Q4 2022 | $19,312 | -25.7% | 665 | -22.9% | 0.00% | – |
| Q3 2022 | $26,000 | -18.8% | 863 | -2.9% | 0.00% | – |
| Q2 2022 | $32,000 | -20.0% | 889 | -4.8% | 0.00% | – |
| Q1 2022 | $40,000 | -14.9% | 934 | -1.7% | 0.00% | – |
| Q4 2021 | $47,000 | 0.0% | 950 | +27.0% | 0.00% | – |
| Q3 2021 | $47,000 | -32.9% | 748 | -22.5% | 0.00% | – |
| Q2 2021 | $70,000 | -18.6% | 965 | -17.4% | 0.00% | – |
| Q1 2021 | $86,000 | -2.3% | 1,168 | -2.3% | 0.00% | – |
| Q4 2020 | $88,000 | +450.0% | 1,196 | +294.7% | 0.00% | – |
| Q3 2020 | $16,000 | -20.0% | 303 | 0.0% | 0.00% | – |
| Q2 2020 | $20,000 | -84.6% | 303 | -85.6% | 0.00% | – |
| Q1 2020 | $130,000 | +712.5% | 2,107 | +1038.9% | 0.00% | – |
| Q4 2019 | $16,000 | +300.0% | 185 | +262.7% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 51 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 51 | -5.6% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 54 | +5.9% | 0.00% | – |
| Q4 2018 | $4,000 | -20.0% | 51 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | -91.5% | 51 | -90.0% | 0.00% | – |
| Q2 2018 | $59,000 | -87.8% | 509 | -89.6% | 0.00% | – |
| Q1 2018 | $482,000 | -31.9% | 4,878 | -27.9% | 0.00% | – |
| Q4 2017 | $708,000 | -66.7% | 6,761 | -64.2% | 0.00% | – |
| Q3 2017 | $2,126,000 | -13.0% | 18,862 | -13.5% | 0.00% | – |
| Q2 2017 | $2,443,000 | +1.8% | 21,794 | +5.9% | 0.00% | – |
| Q1 2017 | $2,399,000 | +14.3% | 20,571 | +3.2% | 0.00% | – |
| Q4 2016 | $2,099,000 | +59.9% | 19,938 | +67.9% | 0.00% | – |
| Q3 2016 | $1,313,000 | -7.0% | 11,878 | +22.5% | 0.00% | – |
| Q2 2016 | $1,412,000 | +1.2% | 9,696 | -0.5% | 0.00% | – |
| Q1 2016 | $1,395,000 | +478.8% | 9,740 | +526.0% | 0.00% | – |
| Q4 2015 | $241,000 | +2310.0% | 1,556 | +2155.1% | 0.00% | – |
| Q3 2015 | $10,000 | -96.5% | 69 | -96.5% | 0.00% | – |
| Q2 2015 | $286,000 | -16.9% | 1,989 | -18.3% | 0.00% | – |
| Q1 2015 | $344,000 | +12.1% | 2,436 | +17.4% | 0.00% | – |
| Q4 2014 | $307,000 | +2092.9% | 2,075 | +2258.0% | 0.00% | – |
| Q3 2014 | $14,000 | -80.0% | 88 | -82.4% | 0.00% | – |
| Q2 2014 | $70,000 | -49.6% | 500 | -60.1% | 0.00% | – |
| Q1 2014 | $139,000 | +135.6% | 1,253 | +108.8% | 0.00% | – |
| Q4 2013 | $59,000 | +28.3% | 600 | 0.0% | 0.00% | – |
| Q3 2013 | $46,000 | -69.5% | 600 | -77.8% | 0.00% | – |
| Q2 2013 | $151,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |